Press Archives

February 16, 2017

Lisa M. Guay-Woodford, M.D., director of the Clinical and Translational Science Institute at Children’s National (CTSI-CN) and Hudson Professor of Pediatrics and Associate Vice President for Clinical and Translational Science, and Robert H. Miller, Ph.D., co-director of the CTSI-CN and Senior Associate Dean for Research, received funding to continue the collaborative pediatric-focused translational research occuring at Children's National Health System and at GW. 

February 09, 2017

Chiara Manzini, Ph.D., assistant professor in pharmacology & physiology, published research in the American Journal of Human Genetics about a newly discovered mutation in the INPP5K gene, which leads to short stature, muscle weakness, intellectual disability, and cataracts, and suggests a new type of congenital muscular dystrophy. 

January 10, 2017

The GW Cancer Center is pleased to announce Robert Siegel, M.D. ’77, professor of medicine, as the new associate center director for education, training, and network development. 

January 05, 2017

A large international survey, published in the Journal of the European Academy of Dermatology & Venereology by researchers from La Roche-Posay and GW, asked nearly 20,000 participants about their sun protection behavior and skin cancer awareness.

December 09, 2016

GW formally launched the GW Cancer Center with a ribbon-cutting and grand opening celebration the evening of Wednesday, Dec. 7.

December 05, 2016

GW is pleased to formally launch the GW Cancer Center with a ribbon cutting ceremony and grand opening celebration. The event will be held at the GW Cancer Center’s new lab and office space located on the eighth floor of the GW Science and Engineering Hall on Wed., Dec. 7 at 5:30 p.m. 

November 30, 2016

Matthew Colonnese, Ph.D., assistant professor of pharmacology and physiology, published a paper in the Journal of Neuroscience establishing a mouse model for human fetal electrographic development. 

November 28, 2016

Narine Sarvazyan, Ph.D., professor of pharmacology and physiology, parntered with Noctural Product Development to receive a $2.27 million Phase II STTR grant to support ongoing efforts to design, produce, and test real-time lesion visualization tools for cardiac ablation procedures.